HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armando Santoro Selected Research

ErbB Receptors (EGF Receptor)

1/2019Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.
1/2019Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition.
3/2018Never too old to fight breast cancer: A case report.
10/2015Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.
4/2015Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer.
3/2013Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors.
3/2012Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.
3/2010Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib.
4/2009Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients.
10/2007EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Armando Santoro Research Topics

Disease

147Neoplasms (Cancer)
03/2024 - 01/2002
59Breast Neoplasms (Breast Cancer)
03/2024 - 01/2003
50Hodgkin Disease (Hodgkin's Disease)
03/2024 - 09/2006
43Hepatocellular Carcinoma (Hepatoma)
04/2024 - 09/2006
38Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 08/2003
36Disease Progression
01/2023 - 01/2002
24Neoplasm Metastasis (Metastasis)
08/2022 - 05/2004
23Lymphoma (Lymphomas)
01/2023 - 04/2002
20Malignant Mesothelioma
05/2023 - 03/2006
19Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 07/2004
16Sarcoma (Soft Tissue Sarcoma)
01/2023 - 04/2008
16Neutropenia
05/2022 - 07/2008
14Diarrhea
10/2023 - 07/2008
11COVID-19
01/2023 - 07/2020
10Fatigue
01/2023 - 01/2009
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 01/2012
9Glioblastoma (Glioblastoma Multiforme)
06/2021 - 02/2007
8Brain Neoplasms (Brain Tumor)
12/2023 - 08/2003
8Thymoma (Thymic Carcinoma)
11/2023 - 03/2009
8Glioma (Gliomas)
01/2023 - 02/2007
7Exanthema (Rash)
04/2024 - 04/2005
7Nausea
04/2024 - 05/2010
7B-Cell Lymphoma (Lymphoma, B Cell)
09/2023 - 04/2005
6Hematologic Neoplasms (Hematological Malignancy)
07/2023 - 08/2003
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 08/2003
6Hypertension (High Blood Pressure)
11/2021 - 01/2009
6Abdominal Pain (Pain, Abdominal)
01/2018 - 01/2009
5Fever (Fevers)
04/2024 - 12/2010
5Adenocarcinoma
04/2024 - 05/2017
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2024 - 01/2002
5Vomiting
04/2024 - 05/2010
5Melanoma (Melanoma, Malignant)
12/2023 - 09/2010
5Infections
01/2023 - 01/2006
5Cardiotoxicity
01/2023 - 10/2013
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2022 - 04/2011
5Febrile Neutropenia
05/2022 - 04/2005
5Pneumonia (Pneumonitis)
01/2022 - 01/2018
5Fibrosis (Cirrhosis)
01/2021 - 03/2011
5Spinal Cord Compression
05/2012 - 01/2010
5Thrombosis (Thrombus)
11/2006 - 02/2003
4Renal Cell Carcinoma (Grawitz Tumor)
12/2023 - 06/2011
4Lung Neoplasms (Lung Cancer)
12/2023 - 10/2010
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2023 - 10/2018

Drug/Important Bio-Agent (IBA)

35Sorafenib (BAY 43-9006)FDA Link
10/2022 - 09/2006
28Biomarkers (Surrogate Marker)IBA
12/2023 - 09/2006
19Immune Checkpoint InhibitorsIBA
04/2024 - 12/2016
18NivolumabIBA
03/2024 - 09/2016
16PlatinumIBA
10/2022 - 06/2007
15Cisplatin (Platino)FDA LinkGeneric
01/2020 - 05/2004
14Brentuximab VedotinIBA
03/2024 - 08/2013
14Hormones (Hormone)IBA
03/2024 - 11/2010
14Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2023 - 01/2015
13Pemetrexed (MTA)FDA Link
01/2022 - 03/2006
13ErbB Receptors (EGF Receptor)IBA
01/2019 - 08/2003
12Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 05/2004
11GemcitabineFDA Link
10/2023 - 01/2007
11DNA (Deoxyribonucleic Acid)IBA
09/2023 - 03/2010
11ARQ 197IBA
01/2019 - 01/2013
9AnthracyclinesIBA
10/2023 - 01/2006
9Tyrosine Kinase InhibitorsIBA
01/2023 - 08/2005
9IfosfamideFDA LinkGeneric
12/2019 - 04/2002
8pembrolizumabIBA
03/2024 - 01/2017
8Trastuzumab (Herceptin)FDA Link
10/2023 - 02/2006
8Rituximab (Mabthera)FDA Link
01/2023 - 09/2003
7Proteins (Proteins, Gene)FDA Link
10/2023 - 09/2010
7regorafenibIBA
01/2023 - 11/2013
7Phenobarbital (Luminal)FDA Link
06/2022 - 01/2020
7Vinorelbine (Navelbine)FDA LinkGeneric
01/2022 - 01/2003
7Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 08/2005
6Cetuximab (Erbitux)FDA Link
12/2023 - 07/2004
6B7-H1 AntigenIBA
11/2023 - 01/2017
6Monoclonal AntibodiesIBA
11/2023 - 08/2005
6LigandsIBA
12/2021 - 09/2016
6Bendamustine HydrochlorideFDA Link
11/2021 - 09/2011
5AntibodiesIBA
02/2024 - 03/2009
5MicroRNAs (MicroRNA)IBA
01/2024 - 01/2020
5copanlisibIBA
11/2021 - 12/2017
5Temozolomide (Temodar)FDA LinkGeneric
06/2021 - 02/2007
5liposomal doxorubicin (Doxil)FDA Link
10/2020 - 01/2003
5Docetaxel (Taxotere)FDA Link
03/2019 - 05/2008
5Carboplatin (JM8)FDA LinkGeneric
03/2019 - 04/2005
5Phosphotransferases (Kinase)IBA
01/2019 - 09/2006
5thiamine triphosphorate (TTP)IBA
07/2013 - 09/2006
5Warfarin (Coumadin)FDA LinkGeneric
01/2006 - 02/2003
4spartalizumabIBA
04/2024 - 10/2020
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2023 - 10/2006

Therapy/Procedure

103Therapeutics
04/2024 - 08/2003
95Drug Therapy (Chemotherapy)
03/2024 - 01/2002
44Radiotherapy
12/2023 - 01/2002
34Stem Cell Transplantation
03/2024 - 02/2007
22Immunotherapy
04/2024 - 06/2015
13Hematopoietic Stem Cell Transplantation
05/2024 - 01/2007
8Salvage Therapy
09/2023 - 07/2012
8Neoadjuvant Therapy
07/2023 - 01/2007
8Adjuvant Chemotherapy
02/2022 - 01/2006
8Haploidentical Transplantation
01/2021 - 01/2018
8Transplantation
01/2021 - 05/2009
6Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020 - 07/2010
6Catheters
12/2017 - 02/2003
5Central Venous Catheters
12/2017 - 02/2003